Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy

Steven Simoens; Peter R. Sinnaeve

首页> 外文期刊>Cardiovascular Drugs and Therapy >Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy

【24h】

Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy

机译：通用阿托伐他汀，比利时他汀类药物市场和他汀类药物治疗的成本-效果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose This study examines how the market entry of generic atorvastatin influences the Belgian statin market and the cost-effectiveness of statin therapy.

机译：目的本研究探讨了通用阿托伐他汀的市场准入如何影响比利时他汀类药物市场以及他汀类药物治疗的成本效益。

著录项

来源
《Cardiovascular Drugs and Therapy》 |2013年第1期|49-60|共12页
作者
Steven Simoens; Peter R. Sinnaeve;
展开▼
作者单位

Research Centre for Pharmaceutical Care and Pharmaco-economics KU Leuven">(1);

Department of Cardiovascular Medicine University Hospitals Leuven">(2);

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Atorvastatin; Generic; Statin; Cost-effectiveness; Savings;

机译：阿托伐他汀;通用他汀类药物;成本效益;积蓄;

相似文献

外文文献
中文文献
专利

1. Generic atorvastatin, the Belgian statin market and the cost-effectiveness of statin therapy [J] . SimoensS., SinnaeveP.R. Cardiovascular drugs and therapy . 2013,第1期

机译：通用阿托伐他汀，比利时他汀类药物市场和他汀类药物治疗的成本效益
2. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial. [J] . Murphy SA, Cannon CP, Wiviott S Journal of the American College of Cardiology . 2009,第25期

机译：在PROVE IT-TIMI 22（普伐他汀或阿托伐他汀评估和心肌梗塞的感染治疗-血栓溶解）试验中，与急性冠状动脉综合征后中度降脂他汀类药物治疗相比，强化降脂他汀类药物治疗减少了复发性心血管事件。
3. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. [J] . Lazar LD, Pletcher MJ, Coxson PG, Circulation: An Official Journal of the American Heart Association . 2011,第2期

机译：他汀类药物疗法在低成本他汀类药物时代的一级预防的成本效益。
4. Decreased Inflammatory Markers in Diabetic Patients with Angiographically Proved Coronary Artery Disease after 18 Months of Statins Therapy [C] . DANIEL LIGHEZAN, ROXANA BUZAS, CORINA SERBAN, Advances in environment, biotechnology and biomedicine . 2012

机译：他汀类药物治疗18个月后，经血管造影证实为冠状动脉疾病的糖尿病患者的炎症指标降低
5. Statin Therapy Associated with Improved Thrombus Resolution in Patients with Deep Vein Thrombosis [D] . Hsu, Charles. 2020

机译：与深静脉血栓形成患者的改善血栓分辨率相关的他汀类药物治疗
6. Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas [O] . Xieda Zhou, Liting Wu, Yan Chen, 2021

机译：2型糖尿病患者患有下肢动脉粥样硬化疾病的408周疗法：比较脱抗属和阿托伐他汀对较低股骨总斑块区域的影响
7. PCV107 Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy [O] . Simoens S., Sinnaeve P. 2012

机译：PCV107通用阿托伐他汀，比利时他汀类药物市场和他汀类药物治疗的成本-效果

Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅